Publications by authors named "Shinmee Mah"

Claim this Profile
K
Kinase and GPCR polypharmacological approach for the identification of efficient anticancer medicines.
Hwangseo Park, Hoi-Yun Jung, Shinmee Mah, Kewon Kim, Sungwoo Hong

Org Biomol Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HS‑146, a novel phosphoinositide 3‑kinase α inhibitor, induces the apoptosis and inhibits the metastatic ability of human breast cancer cells.
Ok Hyeon Kim, Ju-Hee Lee, Shinmee Mah, Sung Yun Park, Sungwoo Hong

Int J Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
Jung Hee Park, Kyung Hee Jung, Soo Jung Kim, Young-Chan Yoon, Hong Hua Yan, Shinmee Mah

Cancer Lett· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase.
Shinmee Mah, Jaebong Jang, Daesun Song, Yongje Shin, Muhammad Latif

Org Biomol Chem· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis.
Han-Hee Park, Se-Yeon Park, Shinmee Mah, Jung-Hee Park, Soon-Sun Hong

Exp Mol Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Computational Design and Identification of Low Picomolar Inhibitors of Aurora Kinase A.
Hwangseo Park, Hoi-Yun Jung, Shinmee Mah, Sungwoo Hong

J Chem Inf Model· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.
Shinmee Mah, Jung Hee Park, Hoi-Yun Jung, Kukcheol Ahn, Soyeon Choi

J Med Chem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.
Shinmee Mah, Jung Hee Park, Hoi-Yun Jung, Kukcheol Ahn, Soyeon Choi

J Med Chem· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA.
Taek-In Oh, Yoon-Mi Lee, Taek-Jin Nam, Young-San Ko, Shinmee Mah

Int J Mol Sci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of EGF Receptor Inhibitors That Are Selective for the d746-750/T790M/C797S Mutant through Structure-Based de Novo Design.
Hwangseo Park, Hoi-Yun Jung, Shinmee Mah, Sungwoo Hong

Angew Chem Int Ed Engl· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through Structure-Based Virtual Screening.
Saemina Shin, Shinmee Mah, Sungwoo Hong, Hwangseo Park

J Chem Inf Model· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalyst Controlled Divergent C4/C8 Site-Selective C-H Arylation of Isoquinolones.
Soyoung Lee, Shinmee Mah, Sungwoo Hong

Org Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis